Cargando…
BEZ235: When Promising Science Meets Clinical Reality
An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The study was terminated early due to toxicity and a lack of clinical efficacy. The rapid and concise publication of this type of clinical result i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016067/ https://www.ncbi.nlm.nih.gov/pubmed/27566248 http://dx.doi.org/10.1634/theoncologist.2016-0243 |
_version_ | 1782452536795463680 |
---|---|
author | Pongas, Georgios Fojo, Tito |
author_facet | Pongas, Georgios Fojo, Tito |
author_sort | Pongas, Georgios |
collection | PubMed |
description | An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The study was terminated early due to toxicity and a lack of clinical efficacy. The rapid and concise publication of this type of clinical result is necessary for effective collaboration and, ultimately, better outcomes for cancer patients. |
format | Online Article Text |
id | pubmed-5016067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AlphaMed Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50160672016-09-14 BEZ235: When Promising Science Meets Clinical Reality Pongas, Georgios Fojo, Tito Oncologist Commentary An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The study was terminated early due to toxicity and a lack of clinical efficacy. The rapid and concise publication of this type of clinical result is necessary for effective collaboration and, ultimately, better outcomes for cancer patients. AlphaMed Press 2016-09 2016-08-26 /pmc/articles/PMC5016067/ /pubmed/27566248 http://dx.doi.org/10.1634/theoncologist.2016-0243 Text en ©AlphaMed Press |
spellingShingle | Commentary Pongas, Georgios Fojo, Tito BEZ235: When Promising Science Meets Clinical Reality |
title | BEZ235: When Promising Science Meets Clinical Reality |
title_full | BEZ235: When Promising Science Meets Clinical Reality |
title_fullStr | BEZ235: When Promising Science Meets Clinical Reality |
title_full_unstemmed | BEZ235: When Promising Science Meets Clinical Reality |
title_short | BEZ235: When Promising Science Meets Clinical Reality |
title_sort | bez235: when promising science meets clinical reality |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016067/ https://www.ncbi.nlm.nih.gov/pubmed/27566248 http://dx.doi.org/10.1634/theoncologist.2016-0243 |
work_keys_str_mv | AT pongasgeorgios bez235whenpromisingsciencemeetsclinicalreality AT fojotito bez235whenpromisingsciencemeetsclinicalreality |